Synthesis of sugar-modified analogs of bredinin (mizoribine), a clinically useful immunosuppressant, by a novel photochemical imidazole ring-cleavage reaction as the key step

Journal of the Chemical Society, Perkin Transactions 1

Volumn , Issue 21, 2000, Pages 3603-3609

  Shuto, Satoshi ^a   Haramuishi, Kimiyo ^a   Fukuoka, Masayoshi ^a   Matsuda, Akira ^a  

^a HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROGENATION; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PHOTOCHEMICAL REACTIONS; SUGAR (SUCROSE); SYNTHESIS (CHEMICAL);

RING-CLEAVAGE REACTIONS;

AROMATIC COMPOUNDS;

EID: 0034619657     PISSN: 14704358     EISSN: None     Source Type: Journal    
DOI: 10.1039/b005510g     Document Type: Article

References (24)

1. This report constitutes Part 202 of our series Nucleosides and Nucleotides. Part 201: T. Umino, N. Minakawa and A. Matsuda, Tetrahedron Lett., 2000, 41, 6419.
2. (a) K. Mizuno, M. Tsujino, M. Takada, M. Hayashi, K. Atsumi, K. Asano and T. Matsuda, J. Antibiot., 1974, 27, 775;
3. (b) H. Yoshioka, K. Nakatsu, M. Hayashi and K. Mizuno, Tetrahedron Lett., 1975, 4031.
4. (a) H. Amemiya and H. Itoh, in Immunosuppressive Drugs: Developments in Anti-rejection Therapy, ed. A. W. Thomson and T. E. Starzl, Edward Arnold, London, 1993, pp. 161-176;
5. (b) S. A. Giruber, Immunol. Rev., 1992, 129, 5;
6. (c) Y. Shiokawa, M. Honma, K. Shichikawa, A. Miyamoto, S. Hirose, T. Nobunaga, H. Mizushima, S. Sugawara, S. Warabi, H. Kondo and K. Ogawa, Jpn. J. Inflammation, 1991, 11, 375;
7. (d) H. Ishikawa, Curr. Med. Chem., 1999, 6, 575.
8. (a) L. A. Turka, J. Dayton, G. Sinclair, C. B. Thompson and B. S. Mitchell, J. Clin. Invest., 1991, 87, 940;
9. (b) J. S. Dayton, L. A. Turka, C. B. Thompson and B. S. Mitchell, Mol. Pharmacol., 1992, 41, 671.
10. (a) S. Shuto, H. Itoh, E. Endo, K. Fukukawa, M. Tsujino and T. Ueda, Chem. Pharm. Bull., 1987, 35, 3523;
11. (b) N. Yoshida, M. Nakamura, M. Fukui, S. Morisada, S. Ogino, M. Inaba, S. Tsukagoshi and Y. Sakurai, Cancer Res., 1983, 43, 5851;
12. (c) M. Fukui, M. Inaba, S. Tsukagoshi and Y. Sakurai, Cancer Res., 1982, 42, 1098.
13. Y. Kosugi, Y. Saito, S. Mori, J. Watanabe, M. Baba and S. Shigeta, Antiviral Chem. Chemother., 1994, 5, 366.
14. (a) K. Fukukawa, S. Shuto, T. Hirano and T. Ueda, Chem. Pharm. Bull., 1986, 34, 3653;
15. (b) K. Fukukawa, S. Shuto, T. Hirano and T. Ueda, Chem. Pharm. Bull., 1984, 32, 1644.
16. A part of this study has been described in a communication: S. Shuto, K. Haramuishi and A. Matsuda, Tetrahedron Lett., 1996, 37, 187.
17. M. Waki and J. Meienhofer, J. Org. Chem., 1977, 42, 2019.
18. H. Koyama and M. Tsuji, Biochem. Pharmacol., 1983, 32, 200.
19. M. Yoshikawa, T. Kato and T. Takenishi, Bull. Chem. Soc. Jpn., 1969, 42, 3505.
20. H. Watababe, unpublished results: when bredinin was subjected to Yoshikawa's procedure, dehydration of the 4-carbamoyl moiety occurred, giving the corresponding 4-cyano derivative as the major product.
21. Y. Watanabe, Y. Komoda, K. Ebisuya and S. Ozaki, Tetrahedron Lett., 1990, 31, 255.
22. G. Weber, M. E. Burt, R. C. Jackson, N. Prajda, M. S. Lui and E. Takeda, Cancer Res., 1983, 43, 1019.
23. A similar activation of 5′-deoxy-5-fluorouridine (doxifluridine), a clinically useful anticancer drug, by nucleoside phosphorylase in tumor cells is known: J.-P. Sommadossi, C. Aubert, J.-P. Cano, J. Gouveia, P. Ribaud and G. Mathe, Cancer Res., 1983, 43, 930.
24. G. J. Atwell and W. A. Denny, Synthesis, 1984, 1032.